Future of Health Data
Summit Replays

Given the intense focus on the development of COVID-19 vaccines, clinical trials emerged at the forefront of the national conversation. This also brought increased interest in “Decentralized Clinical Trials” (DCTs): technology and practices that allow for more patient-centric trial operations.

vision of the future of pharma companies and the role data will increasingly play in that development.

The United States has the highest maternal mortality rate in the developed world. While maternal mortality rates have dropped globally year-over-year, they are persistently rising in the United States. Studies show that access to healthcare is a critical lever for improving outcomes for mothers, particularly women of color.

The entire medical infrastructure received the largest shock in a century with COVID-19. It also paved the way for some of the most impressive feats in modern health care, from historically fast clinical trials to large, interdisciplinary, inter-organization data sharing.

Health and healthcare disparities are driven by complex and interlocking factors within and beyond systems of care. In the wake of COVID-19, the new and long-standing disparities in healthcare access, delivery, and outcomes are increasingly evident.

Speaker: Senator Tom Daschle, Founder & CEO, The Daschle Group & Former Senate Majority Leader, Steve Swank, Chief Business Officer, Datavant

Moderated by Sam Roosz, Speaker: Janet Woodcock

Moderated by Jacob Plummer, Speaker: Robert Califf

Moderated by Vivek Ramaswamy, Speakers: Donna Cryer, Glen de Vries, Jamie MacDonald, Andrew Plump